LTS Lohmann Therapie-Systeme AG;Santhera Pharmaceuticals (Schweitz) AG
发明人:
Markus KRUMME,Keith JENSEN,Judith DUBACH-POWELL,Rudolf HAUSMANN
申请号：
US16531707
公开号：
US20190350872A1
申请日:
2019.08.05
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention generally relates to transmucosal administration systems for administering quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The present invention more specifically relates to methods of treatment for Duchenne Muscular Dystrophy that includes administering to a patient a dose in the form of one or more transmucosal administration systems.
